A critical breakthrough in cancer investigation is emerging with the use of mini-antibodies to re-engage damaged p53. This crucial cancer inhibitor protein is frequently inactivated in several kinds of tumors, leading https://easiestbookmarks.com/story22063187/nanobodies-reactivate-the-p53-protein-new-new-approach-for-cancer-treatment